Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma

• Status: RECRUITING
• Trial end date: 2029-11-20

Summary

The purpose of this study is to compare the effectiveness and safety of golcadomide in combination with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy vs placebo in combination with R-CHOP chemotherapy in participants with previously untreated high-risk large B-cell lymphoma (LBCL).

• Phase: PHASE3

Details

• Lead Sponsor: Celgene
• Treatments: Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine